Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Virolab, Inc.Financial_Report.xls
XML - IDEA: XBRL DOCUMENT - Virolab, Inc.R6.htm
XML - IDEA: XBRL DOCUMENT - Virolab, Inc.R1.htm
XML - IDEA: XBRL DOCUMENT - Virolab, Inc.R4.htm
XML - IDEA: XBRL DOCUMENT - Virolab, Inc.R9.htm
XML - IDEA: XBRL DOCUMENT - Virolab, Inc.R8.htm
XML - IDEA: XBRL DOCUMENT - Virolab, Inc.R5.htm
XML - IDEA: XBRL DOCUMENT - Virolab, Inc.R7.htm
XML - IDEA: XBRL DOCUMENT - Virolab, Inc.R3.htm
XML - IDEA: XBRL DOCUMENT - Virolab, Inc.R12.htm
XML - IDEA: XBRL DOCUMENT - Virolab, Inc.R13.htm
XML - IDEA: XBRL DOCUMENT - Virolab, Inc.R14.htm
XML - IDEA: XBRL DOCUMENT - Virolab, Inc.R11.htm
XML - IDEA: XBRL DOCUMENT - Virolab, Inc.R16.htm
XML - IDEA: XBRL DOCUMENT - Virolab, Inc.R15.htm
XML - IDEA: XBRL DOCUMENT - Virolab, Inc.R10.htm
10-Q/A - AMENDMENT NO. 1 TO QUARTERLY REPORT TO ADD XBRL - Virolab, Inc.viro10qa6302012.htm
v2.4.0.6
BALANCE SHEETS (USD $)
Jun. 30, 2012
Mar. 31, 2012
Current assets:    
Cash and cash equivalents $ 8 $ 40
Total Assets 8 40
Current liabilities:    
Accrued expenses due to founder 94,295 81,295
Other accounts payable 1,880 1,880
Total liabilities 96,175 83,175
Stockholders' deficit:    
Preferred stock, $0.0001 par value, 10,000,000 shares authorized; none issued or outstanding      
Common stock, $0.0001 par value, 100,000,000 shares authorized, 25,350,000 shares issued and outstanding 2,535 2,535
Additional paid-in capital 2,674,913 2,150,850
Deficit accumulated during the development stage (2,773,615) (2,236,520)
Total stockholders' deficit (96,167) (83,135)
Total Liabilities and Stockholders' Equity $ 8 $ 40